JP4270174B2 - Aggregation apparatus and aggregation method - Google Patents

Aggregation apparatus and aggregation method Download PDF

Info

Publication number
JP4270174B2
JP4270174B2 JP2005196242A JP2005196242A JP4270174B2 JP 4270174 B2 JP4270174 B2 JP 4270174B2 JP 2005196242 A JP2005196242 A JP 2005196242A JP 2005196242 A JP2005196242 A JP 2005196242A JP 4270174 B2 JP4270174 B2 JP 4270174B2
Authority
JP
Japan
Prior art keywords
absorbance
flocculant
added
raw water
addition amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005196242A
Other languages
Japanese (ja)
Other versions
JP2006272310A (en
Inventor
繁樹 澤田
景二郎 多田
俊之 齋江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kurita Water Industries Ltd
Original Assignee
Kurita Water Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurita Water Industries Ltd filed Critical Kurita Water Industries Ltd
Priority to JP2005196242A priority Critical patent/JP4270174B2/en
Publication of JP2006272310A publication Critical patent/JP2006272310A/en
Application granted granted Critical
Publication of JP4270174B2 publication Critical patent/JP4270174B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Description

本発明は、天然水を原料とする用水処理や、工場排水又は下水等を処理する廃水処理において、原水に無機凝集剤及び塩素系薬剤を添加することにより、原水中の懸濁物質、コロイダル成分や有機物質を凝結かつ粗大化させる凝集装置及び凝集方法に関する。   The present invention relates to a waste water treatment using natural water as a raw material, a waste water treatment for treating factory wastewater or sewage, etc., by adding an inorganic flocculant and a chlorinated chemical to the raw water, thereby suspending the suspended matter in the raw water, colloidal components Further, the present invention relates to a coagulation apparatus and a coagulation method for coagulating and coarsening organic substances.

天然水を原料とする用水処理や、工場排水又は下水等を処理する廃水処理においては、原水に凝集剤を添加して、原水中の懸濁物質、コロイダル成分や有機物質を凝結かつ粗大化させた後、沈殿、浮上、濾過、膜濾過等により固液分離することが行われている。   In water treatment using natural water as raw material and wastewater treatment for treating industrial wastewater or sewage, a flocculant is added to the raw water to condense and coarsen suspended substances, colloidal components and organic substances in the raw water. After that, solid-liquid separation is performed by precipitation, flotation, filtration, membrane filtration or the like.

凝集処理は、後段に位置する沈殿、浮上、濾過、膜濾過等の固液分離効率を高めるためのものであり、凝集剤としては、一般にアルミニウム塩や鉄塩等の無機凝集剤が用いられる。また、無機凝集剤で凝結した粒子を更に粗大化させるための凝集補助剤として高分子凝集剤が併用される場合も多い。   The agglomeration treatment is for increasing the solid-liquid separation efficiency such as precipitation, flotation, filtration, membrane filtration and the like located in the latter stage, and as the aggregating agent, generally an inorganic aggregating agent such as aluminum salt or iron salt is used. In many cases, a polymer flocculant is used in combination as an agglomeration aid for further coarsening the particles coagulated with the inorganic flocculant.

また、原水に無機凝集剤と共に次亜塩素酸ナトリウムや塩素などの塩素系薬剤を併せて添加すると、凝集状態が良好になることが知られている(ただし、塩素系薬剤の添加により凝集状態が向上するメカニズムは解明されていない)。   In addition, it is known that the addition of a chlorine-based chemical agent such as sodium hypochlorite or chlorine together with an inorganic flocculant to raw water improves the aggregation state (however, the addition of a chlorine-based chemical improves the aggregation state. The mechanism of improvement has not been elucidated).

このように原水に無機凝集剤と塩素系薬剤とを併せて添加する場合、塩素系薬剤は処理水中の遊離残留塩素濃度が一定となるように制御されている。   Thus, when adding an inorganic flocculant and a chlorine chemical | medical agent together to raw | natural water, the chlorine chemical | medical agent is controlled so that the free residual chlorine density | concentration in treated water may become fixed.

特許第3205450号公報には、撹拌槽内の凝集フロックの粒径と溶解性有機物の紫外吸光度を測定し、これらの結果に基いて凝集剤添加量を制御し、また、凝集フロックの粒径から撹拌槽の撹拌機の回転数を決定する薬注装置が提案されている。この装置では、撹拌槽内の溶解性有機物濃度、即ち、凝集剤が添加され撹拌されている凝集液の溶解性有機物濃度を検出し、これを凝集フロックの粒径の検出値と共に、凝集剤添加量の制御の指標とし、一方、撹拌強度は、凝集フロックの粒径に基いて設定しているが、十分に満足し得る凝集結果が得られているとは言えず、より一層の改善が望まれている。
特許第3205450号公報
In Japanese Patent No. 3205450, the aggregation floc particle size in the stirring tank and the ultraviolet absorbance of the soluble organic substance are measured, and the amount of flocculant added is controlled based on these results. There has been proposed a chemical injection device that determines the number of rotations of the agitator in the agitation tank. This device detects the concentration of soluble organic matter in the agitation tank, that is, the concentration of soluble organic matter in the coagulating liquid to which the coagulant is added and is stirred, and this is added together with the detected value of the particle size of the coagulation floc. On the other hand, the agitation strength is set based on the particle size of the agglomerated floc, but it cannot be said that a sufficiently satisfactory agglomeration result has been obtained, and further improvement is desired. It is rare.
Japanese Patent No. 3205450

原水の水質が良い場合、無機凝集剤に対して塩素系薬剤を併用する場合の効果がそれ程高くないことがある。従って、上記のように遊離残留塩素濃度が一定となるように塩素系薬剤を添加する添加方式にあっては、原水の水質が良い場合、塩素系薬剤を無駄に添加することになり、徒に薬剤コストが嵩む結果になることがある。   When the quality of the raw water is good, the effect of using a chlorine-based chemical in combination with the inorganic flocculant may not be so high. Therefore, in the addition method in which the chlorine-based chemical is added so that the free residual chlorine concentration becomes constant as described above, if the quality of the raw water is good, the chlorine-based chemical is unnecessarily added. This can result in increased drug costs.

また、原水中の溶存有機物濃度が高い場合に塩素系薬剤を添加すると、処理水中のトリハロメタン濃度が高くなるおそれがある。   Further, when a chlorinated chemical is added when the dissolved organic matter concentration in the raw water is high, the trihalomethane concentration in the treated water may be increased.

本発明は、このような問題点を解決し、原水に無機凝集剤と塩素系薬剤とを添加して凝集処理するに際し、原水の水質に応じて適切な塩素系薬剤の添加量とすることができる凝集装置及び方法を提供することを目的とする。   The present invention solves such a problem, and when adding an inorganic flocculant and a chlorine-based chemical to raw water and aggregating the raw water, an appropriate amount of the chlorine-based chemical should be added according to the quality of the raw water. It is an object of the present invention to provide an aggregating apparatus and method that can be used.

本発明(請求項1)の凝集装置は、原水に凝集剤を添加する凝集剤添加手段と、原水に塩素系薬剤を添加する塩素系薬剤添加手段と、原水の200〜700nmの吸光度を測定する吸光度測定手段と、該吸光度測定手段の測定値に基づいて該塩素系薬剤添加手段による添加量を制御する塩素系薬剤添加量制御手段とを備えてなる凝集装置であって、該塩素系薬剤添加量制御手段は、吸光度が第1閾値aよりも小さいときには該塩素系薬剤を添加せず、吸光度が第1閾値aと第2閾値b(但し、a<b)との間のときには残留塩素濃度が目標値となるように塩素系薬剤を添加し、吸光度が第2閾値bよりも大きいときには該塩素系薬剤を添加しないように制御するものであることを特徴とするものである。 The flocculating apparatus of the present invention (Claim 1) measures the absorbance of 200 to 700 nm of raw water, a flocculant adding means for adding a flocculant to raw water, a chlorinated chemical adding means for adding a chlorinated chemical to raw water, and raw water. and the absorbance measurement unit, a Ru agglomerator name and a chlorine-based agent addition amount control means for controlling the addition amount of the salt Motokei agent adding means based on a measured value of absorbance measurement unit, the salt Motokei agent The addition amount control means does not add the chlorine-based chemical when the absorbance is smaller than the first threshold value a, and the residual chlorine when the absorbance is between the first threshold value a and the second threshold value b (where a <b). The chlorinated chemical is added so that the concentration becomes a target value, and when the absorbance is larger than the second threshold value b, the chlorinated chemical is controlled not to be added .

請求項2の凝集装置は、請求項1において、前記吸光度測定手段は、原水の200〜490nmの紫外部吸光度と500〜700nmの可視部吸光度とを測定可能であり、該吸光度測定手段で測定された紫外部吸光度と可視部吸光度との差に基づいて前記凝集剤添加手段による凝集剤添加量を制御する凝集剤添加量制御手段を備えたことを特徴とするものである。   According to a second aspect of the present invention, there is provided the aggregating apparatus according to the first aspect, wherein the absorbance measuring means is capable of measuring an ultraviolet absorbance at 200 to 490 nm and a visible absorbance at 500 to 700 nm of raw water, and the absorbance measuring means measures the absorbance. And a flocculant addition amount control means for controlling the flocculant addition amount by the flocculant addition means based on the difference between the ultraviolet absorbance and the visible absorbance.

請求項の凝集装置は、請求項1において、前記凝集剤が凝集槽又はそれよりも前段で添加されるよう構成されており、該凝集槽内の凝集状態を検出する凝集状態検出センサが設置されており、該凝集状態検出センサの検出値に基づいて凝集剤添加手段の凝集剤添加量を制御する凝集剤添加量制御手段を備えたことを特徴とするものである。 A flocculating apparatus according to a third aspect is the flocculating apparatus according to the first aspect, wherein the flocculating agent is configured to be added in the flocculating tank or before the flocculating tank. And a flocculant addition amount control means for controlling the flocculant addition amount of the flocculant addition means based on the detection value of the aggregation state detection sensor.

請求項4の凝集装置は、請求項2において、前記凝集剤が凝集槽又はそれよりも前段で添加されるよう構成されており、該凝集槽内の凝集状態を検出する凝集状態検出センサが設置されており、前記凝集剤添加量制御手段は、前記吸光度測定手段で測定された吸光度差と該凝集状態検出センサの検出値とに基づいて凝集剤添加手段の凝集剤添加量を制御するものであることを特徴とするものである。
請求項5の凝集装置は、請求項1ないし4のいずれか1項において、前記塩素系薬剤添加量制御手段は、aとbとの間にa<c<c<……<c<bなる関係のn個の閾値を設定しておき、a〜c、c〜c、………c〜bの間で各々残留塩素濃度の目標値を設定し、この目標値に基づいて塩素系薬剤の添加量を制御することを特徴とする。
請求項6の凝集装置は、 原水に無機凝集剤及び塩素系薬剤を添加することにより凝集処理する凝集方法において、原水の200〜700nmの吸光度を測定し、この測定値に基づいて原水への塩素系薬剤の添加量を制御する凝集方法であって、吸光度が第1閾値aよりも小さいときには該塩素系薬剤を添加せず、吸光度が第1閾値aと第2閾値b(但し、a<b)との間のときには残留塩素濃度が目標値となるように塩素系薬剤を添加し、吸光度が第2閾値bよりも大きいときには該塩素系薬剤を添加しないことを特徴とする。
請求項7の凝集方法は、請求項6において、aとbとの間にa<c<c<……<c<bなる関係のn個の閾値を設定しておき、a〜c、c〜c、………c〜bの間で各々残留塩素濃度の目標値を設定し、この目標値に基づいて塩素系薬剤の添加量を制御することを特徴とする。
According to a fourth aspect of the present invention, there is provided the coagulation apparatus according to the second aspect, wherein the coagulant is added in the coagulation tank or before the coagulation tank, and an aggregation state detection sensor for detecting the aggregation state in the coagulation tank is installed. The flocculant addition amount control means controls the flocculant addition amount of the flocculant addition means based on the absorbance difference measured by the absorbance measurement means and the detection value of the aggregation state detection sensor. It is characterized by being.
Agglomeration apparatus according to claim 5, in any one of claims 1 to 4, wherein the chlorine-based agents amount control means, a <c 1 between a and b <c 2 <...... <c n <N threshold values of the relationship <b are set, a target value of residual chlorine concentration is set between a to c 1 , c 1 to c 2 ,..., C n to b, and this target value is set. The amount of chlorinated drug added is controlled based on the above.
The flocculation apparatus according to claim 6 is a flocculation method in which an inorganic flocculant and a chlorine-based chemical are added to raw water, and the absorbance of raw water is measured at 200 to 700 nm, and chlorine is added to the raw water based on the measured value. In the aggregation method for controlling the amount of addition of the systemic drug, when the absorbance is smaller than the first threshold value a, the chlorine-based drug is not added, and the absorbances are the first threshold value a and the second threshold value b (where a <b ) Is added so that the residual chlorine concentration becomes a target value, and when the absorbance is larger than the second threshold value b, the chlorine-based agent is not added.
The aggregation method according to claim 7 is the aggregation method according to claim 6, wherein n threshold values of a <c 1 <c 2 <... <C n <b are set between a and b. A target value of residual chlorine concentration is set between c 1 , c 1 to c 2 ,..., c n to b, and the addition amount of the chlorinated chemical is controlled based on the target value. .

請求項の凝集方法は、請求項6又は7において、前記凝集剤を凝集槽又はそれよりも前段側で添加するようにした方法であって、該凝集槽内の凝集状態を検出し、該凝集状態の検出値に基づいて原水への凝集剤添加量を制御することを特徴とするものである。 An aggregating method according to claim 8 is the method according to claim 6 or 7 , wherein the aggregating agent is added to the aggregating tank or upstream of the aggregating tank, the aggregating state in the aggregating tank is detected, and The addition amount of the flocculant to the raw water is controlled based on the detected value of the aggregation state.

請求項の凝集方法は、請求項において、該凝集状態の検出値と、原水の200〜490nmの紫外部吸光度と500〜700nmの可視部吸光度との差とに基づいて、原水への凝集剤添加量を制御することを特徴とするものである。 The aggregation method according to claim 9 is the aggregation method according to claim 8 , based on the detected value of the aggregation state and the difference between the ultraviolet absorbance at 200 to 490 nm and the visible absorbance at 500 to 700 nm of the raw water. It is characterized by controlling the additive amount.

原水に無機凝集剤と塩素系薬剤とを添加する凝集方法において、原水の200〜700nmにおける少なくとも1波長の吸光度を測定し、この測定値に基づいて塩素系薬剤の添加量を制御した場合、塩素系薬剤の添加量が適切となる。即ち、原水の水質が良い場合に塩素系薬剤の添加量が低減されると共に、原水中の有機物濃度が高い場合におけるトリハロメタンの生成が低減される。   In the coagulation method of adding an inorganic flocculant and a chlorinated chemical to raw water, when the absorbance of at least one wavelength at 200 to 700 nm of raw water is measured and the amount of chlorinated chemical added is controlled based on this measured value, chlorine Appropriate amount of system drug added. That is, when the quality of the raw water is good, the amount of chlorinated chemical added is reduced, and the generation of trihalomethane is reduced when the concentration of organic substances in the raw water is high.

なお、本発明によると、凝集処理水の有機物濃度が十分に低くなるので、凝集処理水をさらに膜濾過処理する場合、膜の汚染が抑制され、高い膜濾過性能が維持されることも認められた。   In addition, according to the present invention, the organic matter concentration of the agglomerated treated water is sufficiently low, so that when the agglomerated treated water is further subjected to membrane filtration treatment, it is also recognized that the membrane contamination is suppressed and high membrane filtration performance is maintained. It was.

本発明では、無機凝集剤の添加量を原水の紫外部吸光度と可視部吸光度との差に基づいて制御するのが好適である。   In the present invention, it is preferable to control the amount of the inorganic flocculant added based on the difference between the ultraviolet absorbance and the visible absorbance of the raw water.

即ち、天然水の凝集特性を精査したところ、天然水の波長200nm〜490nmの紫外部吸光度と波長500nm〜700nmの可視部吸光度をそれぞれ1波長以上測定した結果から演算された阻害物質濃度と、0.45μmメンブレンフィルターを用いて一定量の試料水を濾過するのに要する時間(以下KMF値という。)から判断した最適凝集剤添加量との間には相関関係があること、また、阻害物質濃度と上記紫外部及び可視部の吸光度との間には次式のように相関があることが見出された。従って、紫外部及び可視部吸光度をそれぞれ1波長以上測定することにより、最適な凝集剤添加量を推算できる。
(阻害物質濃度)=[(全有機物)−(濁度物質)]
=A×[(紫外部吸光度)−(可視部吸光度)]
That is, when examining the aggregation characteristics of natural water, the inhibitor concentration calculated from the result of measuring the ultraviolet absorbance at a wavelength of 200 nm to 490 nm and the visible absorbance at a wavelength of 500 nm to 700 nm, respectively, of natural water, There is a correlation between the optimum amount of flocculant added determined from the time required to filter a certain amount of sample water using a 45 μm membrane filter (hereinafter referred to as KMF value), and the inhibitor concentration It was found that there is a correlation between the absorbance in the ultraviolet region and the visible region as shown in the following equation. Therefore, the optimum amount of the flocculant added can be estimated by measuring the absorbance of the ultraviolet part and the visible part respectively by one wavelength or more.
(Inhibitor concentration) = [(Total organic matter)-(Turbidity substance)]
= A × [(UV absorbance)-(visible absorbance)]

この紫外部吸光度と可視部吸光度とに基づいて凝集剤添加量を制御するには、例えば予めジャーテストを行って紫外部吸光度と可視部吸光度との差と凝集剤の最適添加量との関係を求めておき、この関係に基づいて凝集剤添加量を制御する。   In order to control the addition amount of the flocculant based on the ultraviolet absorbance and the visible absorbance, for example, a jar test is performed in advance to determine the relationship between the difference between the ultraviolet absorbance and the visible absorbance and the optimum addition amount of the flocculant. The amount of flocculant added is controlled based on this relationship.

本発明では、上記のように凝集阻害を発生させる原水中の有機物等の阻害物質濃度を吸光度測定によって検出するだけでなく、さらに凝集槽内の凝集状態を検出し、上記阻害物質量の検出値とこの凝集状態の検出値とに基いて凝集剤の添加量を制御することにより、きわめて良好な凝集処理を行うことができる。なお、凝集槽内の凝集状態の検出結果にのみ基づいて凝集剤の添加量を制御してもよい。   In the present invention, as described above, not only the concentration of an inhibitory substance such as an organic substance in raw water that causes aggregation inhibition is detected by absorbance measurement, but also the aggregation state in the coagulation tank is detected, and the detected value of the amount of the inhibitory substance is detected. By controlling the addition amount of the flocculant based on the detected value of the agglomeration state, a very good agglomeration treatment can be performed. In addition, you may control the addition amount of a coagulant | flocculant based only on the detection result of the aggregation state in a coagulation tank.

凝集状態検出センサとしては、凝集槽内液の凝集粒子間の清澄度を検出する光遮断式微粒子センサ又は光散乱式微粒子センサ等を用いることができる。   As the agglomeration state detection sensor, a light blocking fine particle sensor, a light scattering fine particle sensor, or the like that detects the clarity between the agglomerated particles of the liquid in the agglomeration tank can be used.

以下に図面を参照して本発明の凝集装置及び凝集方法の実施の形態を詳細に説明する。   Embodiments of the aggregating apparatus and the aggregating method of the present invention will be described below in detail with reference to the drawings.

図1は、本発明の凝集装置を備える凝集沈殿装置の実施の形態を示す系統図であるFigure 1 is a system diagram showing an embodiment of a coagulating sedimentation apparatus including a flocculation apparatus of the present invention.

図1において、1は原水槽であり、吸光度センサ11を備える。2は凝集撹拌槽であり、撹拌機12と凝集状態検出センサ13を備える。この凝集攪拌槽2に塩素系薬剤が貯槽6から薬注ポンプ15を介して供給される。3は沈殿槽である。4は凝集剤貯槽であり、薬注ポンプ14を備える。5は制御装置であり、吸光度センサ11の検出値と、凝集状態検出センサ13の検出値が入力され、撹拌機12の撹拌強度制御信号と薬注ポンプ14及び塩素系薬剤薬注ポンプ15の回転数制御信号が出力される。   In FIG. 1, reference numeral 1 denotes a raw water tank, which includes an absorbance sensor 11. Reference numeral 2 denotes a coagulation agitation tank, which includes an agitator 12 and an aggregation state detection sensor 13. A chlorinated chemical is supplied from the storage tank 6 to the agglomeration stirring tank 2 via a chemical injection pump 15. 3 is a settling tank. Reference numeral 4 denotes a flocculant storage tank, which includes a chemical injection pump 14. Reference numeral 5 denotes a control device to which the detection value of the absorbance sensor 11 and the detection value of the aggregation state detection sensor 13 are inputted, and the stirring intensity control signal of the stirrer 12 and the rotation of the chemical injection pump 14 and the chlorine-based chemical chemical injection pump 15. A number control signal is output.

原水は、原水槽1に導入され、吸光度センサ11により200〜700nmの吸光度が測定される。この測定値が制御装置5に入力される。この実施の形態では、この吸光度に基づいて塩素系薬剤の添加量が制御される。   The raw water is introduced into the raw water tank 1, and the absorbance at 200 to 700 nm is measured by the absorbance sensor 11. This measured value is input to the control device 5. In this embodiment, the addition amount of the chlorinated drug is controlled based on the absorbance.

吸光度センサ11は、浸漬型のものであってもバッヂ型のものであってもよい。   The absorbance sensor 11 may be an immersion type or a badge type.

この吸光度センサ11の200〜700nm好ましくは230〜400nmの紫外部の吸光度に基づいて制御装置5によって塩素系薬剤の添加量が制御される。このように200〜700nm特に230〜400nmの紫外部の吸光度に基づいて塩素系薬剤の添加量を制御することにより、原水水質が良好な場合の塩素系薬剤の無駄な添加が抑制されると共に、原水の有機物濃度が高い場合のトリハロメタンの生成が抑制される。この理由については、上記の吸光度が水中の有機物濃度と相関するためであると考えられる。   The addition amount of the chlorine-based chemical is controlled by the control device 5 based on the absorbance of the absorbance sensor 11 in the ultraviolet region of 200 to 700 nm, preferably 230 to 400 nm. Thus, by controlling the addition amount of the chlorinated drug based on the absorbance in the ultraviolet region of 200 to 700 nm, particularly 230 to 400 nm, wasteful addition of the chlorinated drug when the raw water quality is good is suppressed, The production of trihalomethane when the organic matter concentration of raw water is high is suppressed. The reason for this is considered to be because the absorbance described above correlates with the concentration of organic substances in water.

上記吸光度に基づく塩素系薬剤の添加制御としては、a<bなる関係の2個の閾値a,bを予め定めておき、
吸光度がaよりも小さいときには塩素系薬剤を添加せず;
吸光度がa〜bのときには残留塩素濃度が目標値となるように塩素系薬剤を添加し;
吸光度がbよりも大きいときには塩素系薬剤を添加しない;
ような閾値制御である。なお、aとbとの間にa<c<c……<c<bなる関係のn個の閾値を設定しておき、a〜c、c〜c、………c〜bの間で各々残留塩素濃度の目標値を設定してもよい。
Is the control added system of chlorine agent based on the absorbance, a <b consists of two thresholds a relationship determined in advance to b,
When the absorbance is smaller than a, no chlorinated chemical is added;
When the absorbance is a to b, add a chlorinated chemical so that the residual chlorine concentration becomes the target value;
Do not add chlorinated drugs when absorbance is greater than b;
Threshold system, such as a control. It should be noted that n threshold values of a <c 1 <c 2 ... <C n <b are set between a and b, and a to c 1 , c 1 to c 2 ,. it may set a target value of each residual chlorine concentration between c n ~b.

これらの閾値は、予め0.45μmメンブレンフィルターを用いて一定量の試料水を濾過するのに要する時間及びトリハロメタン濃度測定から決定した値であり、必ずしも原水毎に調整する必要はない。   These threshold values are values determined in advance from the time required to filter a certain amount of sample water using a 0.45 μm membrane filter and the measurement of trihalomethane concentration, and need not be adjusted for each raw water.

原水槽1内の原水は次いで凝集撹拌槽2に導入される。凝集撹拌槽2において、原水は、凝集剤貯槽4の凝集剤が薬注ポンプ14により添加されると共に、薬注ポンプ15により塩素系薬剤が添加され、撹拌機12により撹拌されて凝集処理される。この凝集剤添加量は、吸光度センサ11の検出結果に基づいて制御される。   The raw water in the raw water tank 1 is then introduced into the coagulation stirring tank 2. In the flocculation agitation tank 2, the raw water is agglomerated by adding the flocculating agent in the flocculating agent storage tank 4 by the chemical injection pump 14, adding a chlorinated chemical by the chemical injection pump 15, and stirring it by the agitator 12. . The amount of the flocculant added is controlled based on the detection result of the absorbance sensor 11.

一般に、原水中の有機物濃度は、紫外部吸光度と可視部吸光度との差に比例するので、次式のように、紫外部吸光度と可視部吸光度に係数を乗じて凝集剤添加量を演算し、これに基づいて凝集剤添加量を制御することができる。
凝集剤添加量=A×[(紫外部吸光度)−(可視部吸光度)]
Generally, the organic matter concentration in the raw water is proportional to the difference between the ultraviolet absorbance and the visible absorbance, so that the flocculant addition amount is calculated by multiplying the ultraviolet absorbance and the visible absorbance by a coefficient, Based on this, the amount of flocculant added can be controlled.
Addition amount of flocculant = A × [(UV absorbance)-(visible absorbance)]

紫外部吸光度は、200〜490nm特に230〜300nm例えば260nmの吸光度とされ、可視部吸光度は、500〜700nm特に600〜700nm例えば660nmの吸光度とされる。   The ultraviolet absorbance is 200 to 490 nm, particularly 230 to 300 nm, such as 260 nm, and the visible absorbance is 500 to 700 nm, particularly 600 to 700 nm, such as 660 nm.

Aは、予め原水を用いたジャーテストにより測定したKMF値から決定した係数であり、必ずしも原水毎にAを調整する必要はない。   A is a coefficient determined in advance from a KMF value measured by a jar test using raw water, and it is not always necessary to adjust A for each raw water.

なお、このように吸光度差に比例した凝集剤添加量制御の代わりに、吸光度差の閾値に基づく制御としてもよい。この閾値による凝集剤添加制御の方式は、上記の閾値による塩素系薬剤の添加制御の場合と同様である。   In place of the flocculant addition amount control proportional to the absorbance difference, control based on the absorbance difference threshold may be used. The method of controlling the addition of the flocculant by this threshold is the same as the case of the addition control of the chlorinated drug by the above threshold.

凝集撹拌槽2内の凝集状態が凝集状態検出センサ13により検出され、検出結果が制御装置5に入力される。この凝集状態検出センサ13としては、凝集撹拌槽2の液体を別の沈殿槽に移設して、一定時間沈降させた上澄みの濁度を検出する装置とセンサや、凝結ないし凝集した粒子のゼータ電位や流動電位を検出する装置とセンサ等も用いることもできるが、凝集撹拌槽2内にて凝結ないし凝集した粒子間の清澄度を検出する光遮断式微粒子センサや光散乱式微粒子センサが好適に用いられる。   The aggregation state in the aggregation stirring tank 2 is detected by the aggregation state detection sensor 13, and the detection result is input to the control device 5. The agglomeration state detection sensor 13 includes a device and a sensor for detecting the turbidity of a supernatant obtained by transferring the liquid in the agglomeration stirring tank 2 to another sedimentation tank and allowing it to settle for a certain period of time, or the zeta potential of aggregated or agglomerated particles. Although a device and a sensor for detecting the flow potential can also be used, a light blocking fine particle sensor or a light scattering fine particle sensor for detecting the clarity between particles condensed or aggregated in the aggregation stirring tank 2 is preferable. Used.

凝集撹拌槽2の撹拌機12の撹拌強度は吸光度センサ11の検出値に基いて制御される。即ち、例えば、制御装置5において、入力された吸光度センサ11の検出値を予め設定した基準値と比較し、この検出値が基準値を上回る場合には、撹拌強度を上げ、基準値以下であれば撹拌強度を下げるように制御を行う。   The stirring intensity of the stirrer 12 in the aggregation stirring tank 2 is controlled based on the detection value of the absorbance sensor 11. That is, for example, the control device 5 compares the input detection value of the absorbance sensor 11 with a preset reference value, and if this detection value exceeds the reference value, the agitation intensity is increased so that it is below the reference value. If so, control is performed to reduce the stirring intensity.

凝集撹拌槽2の撹拌強度の制御は、撹拌機12の駆動モーターに取り付けられた回転制御装置により、撹拌機12の回転数を制御することにより行うことができる。また、撹拌機12とは別に凝集撹拌槽2内の液を汲み上げて撹拌した後循環させる循環ポンプとスタティックミキサー等の撹拌素子とを備える循環ラインを設け、凝集撹拌槽2内の液を取り出して撹拌した後戻すようにし、この循環ポンプ及び/又は撹拌素子の作動を制御することにより撹拌強度を制御することもできる。また、これらを併用して撹拌強度を制御することもできる。   The stirring strength of the agglomeration stirring tank 2 can be controlled by controlling the number of rotations of the stirrer 12 with a rotation control device attached to the drive motor of the stirrer 12. In addition to the stirrer 12, a circulation line including a circulation pump that pumps and circulates the liquid in the flocculation agitation tank 2 and agitation is provided, and the liquid in the flocculation agitation tank 2 is taken out. It is possible to control the stirring intensity by controlling the operation of the circulation pump and / or the stirring element by returning after stirring. Moreover, stirring intensity can also be controlled using these together.

なお、凝集撹拌槽2への凝集剤添加量は、凝集状態検出センサ13の検出値に基いて制御されてもよい。即ち、例えば、制御装置5において、入力された凝集状態検出センサ13の検出値を予め設定した凝集剤添加量の決定式に代入し、その算出結果に基いて薬注制御してもよい。   Note that the amount of the flocculant added to the aggregation stirring tank 2 may be controlled based on the detection value of the aggregation state detection sensor 13. That is, for example, in the control device 5, the input detection value of the aggregation state detection sensor 13 may be substituted into a preset formula for determining the addition amount of the coagulant, and the chemical injection control may be performed based on the calculation result.

また、凝集剤の添加量は、凝集状態検出センサ13の検出値と、吸光度センサ11の検出値との双方に基づいて制御されてもよい。   Further, the addition amount of the flocculant may be controlled based on both the detection value of the aggregation state detection sensor 13 and the detection value of the absorbance sensor 11.

凝集撹拌槽2への凝集剤添加量を、吸光度センサ11の検出値と凝集状態検出センサ13の検出値とに基いて制御するには、例えば、制御装置5において、入力された吸光度センサ11の検出値を予め設定した凝集剤添加量の決定式に代入し、その算出結果に基いて薬注ポンプ14の回転数を制御すると共に、凝集状態検出センサ13の検出値に基づいて薬注ポンプの回転数を補正する。   In order to control the addition amount of the flocculant to the aggregation stirring tank 2 based on the detection value of the absorbance sensor 11 and the detection value of the aggregation state detection sensor 13, for example, the control device 5 uses the input absorbance sensor 11. The detected value is substituted into a predetermined determination formula for the amount of flocculant added, and the number of revolutions of the medicinal pump 14 is controlled based on the calculation result. Correct the rotation speed.

凝集撹拌槽2内で凝集剤が添加されて撹拌されることにより凝集処理された凝集処理水は、沈殿槽3に導入されて凝結、凝集粒子が沈降分離され、上澄水が処理水として取り出される。   The agglomerated water that has been agglomerated by adding and aggregating the aggregating agent in the agitation agitation tank 2 is introduced into the precipitation tank 3 to coagulate and aggregated particles are settled and separated, and the supernatant water is taken out as treated water. .

なお、図1は本発明の実施の形態の一例を示すものであり、本発明はその要旨を超えない限り、何ら図示のものに限定されるものではない。塩素系薬剤は、図1の通り原水槽1に添加されるのが好ましいが、凝集攪拌槽2に添加されてもよい。   FIG. 1 shows an example of an embodiment of the present invention, and the present invention is not limited to the illustrated one as long as the gist of the present invention is not exceeded. The chlorinated chemical is preferably added to the raw water tank 1 as shown in FIG.

また、図1では、凝集剤を凝集撹拌槽2に添加しているが、凝集剤は、凝集撹拌槽2への原水導入配管に注入しても良い。更に、図1では、凝集処理水の固液分離手段として沈殿槽3を示したが、本発明は沈殿槽に限らず、浮上槽、濾過装置、膜濾過装置等の各種の固液分離手段の前段の凝集手段として有効に適用可能である。本発明では、攪拌は行われなくてもよい。   Further, in FIG. 1, the flocculant is added to the flocculent stirring tank 2, but the flocculant may be injected into the raw water introduction pipe to the flocculent stirring tank 2. Furthermore, although the precipitation tank 3 is shown in FIG. 1 as the solid-liquid separation means of the coagulated treated water, the present invention is not limited to the precipitation tank, but various solid-liquid separation means such as a flotation tank, a filtration apparatus, and a membrane filtration apparatus. It can be effectively applied as an aggregation means in the previous stage. In the present invention, stirring may not be performed.

図示は省略するが、本発明では、凝集攪拌槽2にpHセンサを設け、凝集攪拌槽2内のpHが5.0〜7.0程度となるように酸・アルカリを薬注するようにしてもよい。   Although illustration is omitted, in the present invention, a pH sensor is provided in the agglomeration agitation tank 2, and acid and alkali are poured into the agglomeration agitation tank 2 so that the pH in the agglomeration agitation tank 2 is about 5.0 to 7.0. Also good.

以下に実施例及び比較例を挙げて本発明をより具体的に説明する。   Hereinafter, the present invention will be described more specifically with reference to Examples and Comparative Examples.

実施例1
有機物汚染の進んだA河川を水源とする凝集・沈殿・砂濾過・UF膜濾過施設において、図1に示す凝集沈殿装置を用いて、本発明による凝集沈澱処理を行った。砂濾過は有効径0.45mmの濾過砂を600mm積層したカラムを用いた。凝集撹拌槽は有効容量300mのパドル式撹拌機(60r.p.m.,5kW)付きの角型急速撹拌槽であり、原水量は30m/h、急速撹拌槽の滞留時間は6分とした。
Example 1
In the agglomeration / precipitation / sand filtration / UF membrane filtration facility using the river A where organic matter contamination progressed as a water source, the agglomeration precipitation treatment according to the present invention was performed using the agglomeration precipitation apparatus shown in FIG. For sand filtration, a column in which 600 mm of filtration sand having an effective diameter of 0.45 mm was laminated was used. The coagulation agitation tank is a square rapid agitation tank with a paddle type agitator (60 rpm, 5 kW) having an effective capacity of 300 m 3 , the raw water amount is 30 m 3 / h, and the residence time of the rapid agitation tank is 6 minutes. It was.

塩素系薬剤としては塩素を用いた。塩素の添加量は、原水の260nmの紫外光の吸光度に基づき制御した。即ち、吸光度が0.1[abs./50mm]未満のとき及び0.5[abs./50mm]超のときは塩素を添加せず、0.1〜0.5[abs./50mm]のときは残留塩素濃度が0.5mg/Lとなるように塩素を添加した。この閾値は予めジャーテストを行って決定した。   Chlorine was used as the chlorinated drug. The amount of chlorine added was controlled based on the absorbance of the raw water at 260 nm for ultraviolet light. That is, the absorbance is 0.1 [abs. / 50 mm] and 0.5 [abs. / 50 mm], chlorine is not added, and 0.1 to 0.5 [abs. / 50 mm], chlorine was added so that the residual chlorine concentration was 0.5 mg / L. This threshold was determined in advance by performing a jar test.

凝集剤としてはポリ塩化アルミニウム(PAC)を用いた。なお、PAC添加量は、260nmの紫外部吸光度と660nmの可視部吸光度との差に基づいて制御した。PAC添加量を制御する演算式は、予め、A河川水を用いたジャーテストの結果から求めた。また、凝集撹拌槽のpHは6.5となるように図示しないpH調整手段により単独で自動調整した。   Polyaluminum chloride (PAC) was used as the flocculant. The amount of PAC added was controlled based on the difference between the ultraviolet absorbance at 260 nm and the visible absorbance at 660 nm. The arithmetic expression for controlling the PAC addition amount was obtained in advance from the result of the jar test using the A river water. Further, the pH of the coagulation agitation tank was automatically adjusted independently by a pH adjusting means (not shown) so as to be 6.5.

吸光度センサとしては、波長200nm〜700nm近傍の紫外〜可視光領域を走査できるS::CANセンサ(S::CAN MESSTECHNIK GMBH(オーストリア)製、セル幅35mm)を用いた。   As the absorbance sensor, an S :: CAN sensor (S :: CAN MESSTECHNIK GMBH (Austria), cell width 35 mm) capable of scanning the ultraviolet to visible light region in the vicinity of a wavelength of 200 nm to 700 nm was used.

比較例1
吸光度の測定による塩素注入量の制御を行わなかったこと以外は実施例1と同様の制御を行った。塩素注入量は、遊離残留塩素濃度が0.5mg/Lに維持されるように調整した。
Comparative Example 1
The same control as in Example 1 was performed except that the chlorine injection amount was not controlled by measuring the absorbance. The chlorine injection amount was adjusted so that the free residual chlorine concentration was maintained at 0.5 mg / L.

比較例2
塩素注入それ自体を行わなかったこと以外は実施例1と同様の制御を行った。
Comparative Example 2
The same control as in Example 1 was performed except that chlorine injection itself was not performed.

[実施例と比較例との比較]
11〜12月の晴天、降雨により水質変動が生じた時期にそれぞれ2週間の通水を行った。なお、同じ原水を使用するため、実施例での構成と比較例での構成を並列して行った。通水試験期間中の原水DOCと、PAC添加濃度、凝集沈殿処理水KMF値、UF膜のΔP上昇速度を表1に示した。なお、KMF値とは、直径47mmのメンブレンフィルターを用い、真空吸引圧力500mmHgで濾過した時の最初の500mL濾過時間及びその後の500mL濾過時間を足したものである。
[Comparison between Examples and Comparative Examples]
Water was passed for 2 weeks each when the water quality fluctuated due to fine weather and rainy weather from 11 to December. In addition, in order to use the same raw | natural water, the structure in an Example and the structure in a comparative example were performed in parallel. Table 1 shows the raw water DOC, the PAC addition concentration, the coagulation sedimentation treated water KMF value, and the ΔP increase rate of the UF membrane during the water flow test. The KMF value is obtained by adding the first 500 mL filtration time and the subsequent 500 mL filtration time when filtration is performed at a vacuum suction pressure of 500 mmHg using a membrane filter having a diameter of 47 mm.

実施例1は、比較例2と比較し、KMF値及びΔP上昇速度が低い値で推移した。   In Example 1, compared with Comparative Example 2, the KMF value and the ΔP increase rate were low.

比較例1のトリハロメタン濃度は実施例と比較して、過剰になる場合があった。   The trihalomethane concentration in Comparative Example 1 sometimes became excessive as compared with the Example.

Figure 0004270174
Figure 0004270174

本発明の凝集装置を備える凝集沈殿装置の実施の形態を示す系統図である。It is a systematic diagram which shows embodiment of the coagulation sedimentation apparatus provided with the coagulation apparatus of this invention.

符号の説明Explanation of symbols

1 原水槽
2 凝集撹拌槽
3 沈殿槽
4 凝集剤貯槽
5 制御装置
11 吸光度センサ
12 撹拌機
13 凝集状態検出センサ
14,15 薬注ポンプ
DESCRIPTION OF SYMBOLS 1 Raw water tank 2 Aggregation stirring tank 3 Precipitation tank 4 Coagulant storage tank 5 Control apparatus 11 Absorbance sensor 12 Stirrer 13 Aggregation state detection sensor 14,15 Chemical injection pump

Claims (9)

原水に凝集剤を添加する凝集剤添加手段と、
原水に塩素系薬剤を添加する塩素系薬剤添加手段と、
原水の200〜700nmの吸光度を測定する吸光度測定手段と、
該吸光度測定手段の測定値に基づいて該塩素系薬剤添加手段による添加量を制御する塩素系薬剤添加量制御手段と
を備えてなる凝集装置であって、
該塩素系薬剤添加量制御手段は、
吸光度が第1閾値aよりも小さいときには該塩素系薬剤を添加せず、
吸光度が第1閾値aと第2閾値b(但し、a<b)との間のときには残留塩素濃度が目標値となるように塩素系薬剤を添加し、
吸光度が第2閾値bよりも大きいときには該塩素系薬剤を添加しないように制御するものであることを特徴とする凝集装置。
A flocculant addition means for adding the flocculant to the raw water;
A chlorinated chemical addition means for adding a chlorinated chemical to raw water;
An absorbance measuring means for measuring the absorbance of raw water at 200 to 700 nm;
A Do that agglutination device and a chlorine-based agent addition amount control means for controlling the addition amount of the salt Motokei agent adding means based on a measured value of absorbance measurement means,
The chlorinated drug addition amount control means includes:
When the absorbance is smaller than the first threshold a, the chlorinated drug is not added,
When the absorbance is between the first threshold value a and the second threshold value b (where a <b), a chlorine-based chemical is added so that the residual chlorine concentration becomes a target value,
An aggregating apparatus characterized in that when the absorbance is larger than a second threshold value b, the chlorinated chemical is controlled not to be added.
請求項1において、前記吸光度測定手段は、原水の200〜490nmの紫外部吸光度と500〜700nmの可視部吸光度とを測定可能であり、
該吸光度測定手段で測定された紫外部吸光度と可視部吸光度との差に基づいて前記凝集剤添加手段による凝集剤添加量を制御する凝集剤添加量制御手段を備えたことを特徴とする凝集装置。
In claim 1, the absorbance measuring means can measure the ultraviolet absorbance of raw water 200-490nm and the visible absorbance of 500-700nm,
An aggregating apparatus comprising a flocculant addition amount control means for controlling a flocculant addition amount by the flocculant addition means based on a difference between an ultraviolet absorbance and a visible absorbance measured by the absorbance measuring means. .
請求項1において、
前記凝集剤が凝集槽又はそれよりも前段で添加されるよう構成されており、
該凝集槽内の凝集状態を検出する凝集状態検出センサが設置されており、
該凝集状態検出センサの検出値に基づいて凝集剤添加手段の凝集剤添加量を制御する凝集剤添加量制御手段を備えたことを特徴とする凝集装置。
In claim 1,
The flocculant is configured to be added in the agglomeration tank or upstream thereof,
An aggregation state detection sensor for detecting the aggregation state in the aggregation tank is installed,
An aggregating apparatus comprising an aggregating agent addition amount control unit for controlling an aggregating agent addition amount of the aggregating agent addition unit based on a detection value of the aggregation state detection sensor.
請求項2において、
前記凝集剤が凝集槽又はそれよりも前段で添加されるよう構成されており、
該凝集槽内の凝集状態を検出する凝集状態検出センサが設置されており、
前記凝集剤添加量制御手段は、前記吸光度測定手段で測定された吸光度差と該凝集状態検出センサの検出値とに基づいて凝集剤添加手段の凝集剤添加量を制御するものであることを特徴とする凝集装置。
In claim 2,
The flocculant is configured to be added in the agglomeration tank or upstream thereof,
An aggregation state detection sensor for detecting the aggregation state in the aggregation tank is installed,
The flocculant addition amount control means controls the flocculant addition amount of the flocculant addition means based on the absorbance difference measured by the absorbance measurement means and the detection value of the aggregation state detection sensor. Agglomeration equipment.
請求項1ないし4のいずれか1項において、前記塩素系薬剤添加量制御手段は、aとbとの間にa<c5. The chlorinated drug addition amount control means according to claim 1, wherein: a <c 1 <c<C 2 <……<c<…… <c n <bなる関係のn個の閾値を設定しておき、a〜cN threshold values of the relationship <b are set, and a to c 1 、c, C 1 〜c~ C 2 、………c............ c n 〜bの間で各々残留塩素濃度の目標値を設定し、この目標値に基づいて塩素系薬剤の添加量を制御することを特徴とする凝集装置。A coagulating apparatus characterized in that a target value of residual chlorine concentration is set between ˜b and the amount of chlorinated chemical added is controlled based on this target value. 原水に無機凝集剤及び塩素系薬剤を添加することにより凝集処理する凝集方法において、
原水の200〜700nmの吸光度を測定し、この測定値に基づいて原水への塩素系薬剤の添加量を制御する凝集方法であって、
吸光度が第1閾値aよりも小さいときには該塩素系薬剤を添加せず、
吸光度が第1閾値aと第2閾値b(但し、a<b)との間のときには残留塩素濃度が目標値となるように塩素系薬剤を添加し、
吸光度が第2閾値bよりも大きいときには該塩素系薬剤を添加しないことを特徴とする凝集方法。
In the coagulation method of coagulating by adding an inorganic coagulant and a chlorine-based chemical to raw water,
The absorbance of 200~700nm of the raw water is measured, a chlorine amount that controls the agglutination method of the agent to the raw water on the basis of the measured values,
When the absorbance is smaller than the first threshold a, the chlorinated drug is not added,
When the absorbance is between the first threshold value a and the second threshold value b (where a <b), a chlorine-based chemical is added so that the residual chlorine concentration becomes a target value,
An aggregating method, wherein the chlorine-based chemical is not added when the absorbance is larger than a second threshold value b.
請求項6において、aとbとの間にa<c<c<……<c<bなる関係のn個の閾値を設定しておき、a〜c、c〜c、………c〜bの間で各々残留塩素濃度の目標値を設定し、この目標値に基づいて塩素系薬剤の添加量を制御することを特徴とする凝集方法In claim 6, n threshold values of a <c 1 <c 2 <... <C n <b are set between a and b, and a to c 1 and c 1 to c 2 are set. A coagulation method characterized in that a target value of residual chlorine concentration is set between each of c n to b, and the addition amount of the chlorine-based chemical is controlled based on the target value. 請求項6又は7において、前記凝集剤を凝集槽又はそれよりも前段側で添加するようにした方法であって、
該凝集槽内の凝集状態を検出し、
該凝集状態の検出値に基づいて原水への凝集剤添加量を制御することを特徴とする凝集方法。
The method according to claim 6 or 7 , wherein the flocculant is added on the flocculant tank or on the upstream side thereof.
Detecting the agglomeration state in the agglomeration tank;
A coagulation method characterized by controlling the amount of coagulant added to the raw water based on the detected value of the coagulation state.
請求項において、該凝集状態の検出値と、原水の200〜490nmの紫外部吸光度と500〜700nmの可視部吸光度との差とに基づいて、原水への凝集剤添加量を制御することを特徴とする凝集方法。 In claim 8, the detection value of the aggregated state, on the basis of the difference between the visible portion absorbance ultraviolet absorbance and 500~700nm of 200~490nm of the raw water, to control the flocculant amount to the raw water Aggregation method characterized.
JP2005196242A 2005-03-02 2005-07-05 Aggregation apparatus and aggregation method Expired - Fee Related JP4270174B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005196242A JP4270174B2 (en) 2005-03-02 2005-07-05 Aggregation apparatus and aggregation method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005057725 2005-03-02
JP2005196242A JP4270174B2 (en) 2005-03-02 2005-07-05 Aggregation apparatus and aggregation method

Publications (2)

Publication Number Publication Date
JP2006272310A JP2006272310A (en) 2006-10-12
JP4270174B2 true JP4270174B2 (en) 2009-05-27

Family

ID=37207556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005196242A Expired - Fee Related JP4270174B2 (en) 2005-03-02 2005-07-05 Aggregation apparatus and aggregation method

Country Status (1)

Country Link
JP (1) JP4270174B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4862576B2 (en) * 2006-09-14 2012-01-25 栗田工業株式会社 Aggregation apparatus and aggregation method
JP5210948B2 (en) * 2009-04-10 2013-06-12 株式会社日立製作所 Chemical injection control method for water purification plant

Also Published As

Publication number Publication date
JP2006272310A (en) 2006-10-12

Similar Documents

Publication Publication Date Title
JP4277831B2 (en) Aggregation apparatus and aggregation method
JP4862576B2 (en) Aggregation apparatus and aggregation method
JP4793193B2 (en) Aggregation apparatus and aggregation method
JP2007245078A (en) Water treatment system and water treatment process
JP2009248028A (en) Water treating method and its device
JP5401087B2 (en) Flocculant injection control method
JP4270174B2 (en) Aggregation apparatus and aggregation method
JP2920803B2 (en) Solid-liquid separator
JP2008168199A (en) Membrane separation activated sludge apparatus and its operation method
JP4244769B2 (en) Aggregation apparatus and aggregation method
JP2016131937A (en) Seawater desalination system and method
JP2006055804A (en) Coagulation device, coagulation method and controller for charging chemical
JP6739913B2 (en) Aggregation-precipitation control device, aggregation-precipitation control method and computer program
JP2007203249A (en) Water treating apparatus and method
JP3731454B2 (en) Method for determining amount of coagulant injection and control device for drug injection
JP7074406B2 (en) Drug addition amount control device and drug addition amount control method
JP4985088B2 (en) Chemical injection control method
JP5210948B2 (en) Chemical injection control method for water purification plant
WO2016038726A1 (en) Water treatment apparatus and water treatment method
JP6406375B2 (en) Flocculant injection control method, control device, and water treatment system
JP2018161632A (en) Water treatment apparatus and water treatment method
JP2020203263A (en) Water treatment method and water treatment device
JP5382355B2 (en) Industrial water filtration method and filtration device
JP2000317466A (en) Flocculating and separating device
JPH0729101B2 (en) Inorganic wastewater coagulation treatment device

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070709

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070717

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081118

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090203

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090216

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120306

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120306

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130306

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130306

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140306

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees